Renhai Cao Selected Research

Renhai Cao Research Topics

Disease

26	Neoplasms (Cancer) 01/2016 - 02/2002
10	Neoplasm Metastasis (Metastasis) 01/2016 - 02/2002
6	Lymphatic Metastasis 09/2014 - 06/2002
4	Hypoxia (Hypoxemia) 01/2019 - 06/2006
4	Fibrosarcoma 10/2007 - 02/2002
3	Vascular Remodeling 12/2011 - 09/2007
3	Obesity 01/2009 - 02/2004
2	Ocular Paraneoplastic Syndromes 05/2010 - 01/2010
1	Macular Degeneration (Age-Related Maculopathy) 01/2019
1	Intussusception 01/2019
1	Craniofacial Abnormalities 06/2012
1	Anemia 12/2011
1	Fibrosis (Cirrhosis) 08/2011
1	Heart Failure 08/2011
1	Cardiomegaly (Heart Hypertrophy) 08/2011
1	Ganglion Cysts (Ganglion) 01/2010
1	Breast Neoplasms (Breast Cancer) 11/2008
1	Retinal Neovascularization 07/2008
1	Larsen Syndrome 03/2007
1	Boomerang dysplasia 03/2007
1	Spondylocarpotarsal synostosis 03/2007
1	Hepatocellular Carcinoma (Hepatoma) 06/2006
1	Insulin Resistance 06/2004
1	Pathologic Neovascularization 06/2004
1	Corneal Neovascularization 02/2004
1	Ischemia 05/2003
1	Edema (Dropsy) 03/2003
1	Inflammation (Inflammations) 07/2002
1	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2002
1	Hemorrhage 02/2002

Drug/Important Bio-Agent (IBA)

10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 02/2002
6	Becaplermin (PDGF-BB)FDA Link 01/2016 - 05/2003
5	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 09/2012 - 06/2002
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2011 - 10/2004
4	Angiogenesis InhibitorsIBA 07/2008 - 07/2002
3	Oxygen (Dioxygen)IBA 12/2011 - 06/2006
3	Proteins (Proteins, Gene)FDA Link 12/2011 - 05/2006
3	LigandsIBA 01/2010 - 06/2002
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2010 - 10/2005
2	Sunitinib (Sutent)FDA Link 01/2016 - 07/2008
2	Vascular Endothelial Growth Factor CIBA 09/2012 - 06/2002
2	Matrix Metalloproteinase 14 (MT1-MMP)IBA 08/2012 - 06/2012
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 08/2011 - 05/2006
2	Retinaldehyde (Retinal)IBA 05/2010 - 07/2008
2	CytokinesIBA 07/2008 - 09/2007
2	Laminin (Merosin)IBA 06/2004 - 02/2002
2	Protein Isoforms (Isoforms)IBA 10/2002 - 02/2002
1	tdTomatoIBA 01/2016
1	Interleukin-33IBA 01/2016
1	Type I Tumor Necrosis Factor ReceptorsIBA 09/2014
1	Platelet-Derived Growth FactorIBA 12/2011
1	Messenger RNA (mRNA)IBA 12/2011
1	Erythropoietin FDA Link 12/2011
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2011
1	AntigensIBA 05/2010
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2009
1	Angiogenesis Modulating AgentsIBA 01/2009
1	6-chloropenicillanic acid S-sulfoxideIBA 11/2008
1	Bevacizumab (Avastin)FDA Link 11/2008
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 07/2008
1	ZM323881IBA 07/2008
1	interleukin 20 (IL-20)IBA 09/2007
1	ErbB Receptors (EGF Receptor)IBA 08/2007
1	Microfilament Proteins (Actin Binding Proteins)IBA 03/2007
1	FilaminsIBA 03/2007
1	Transcription Factors (Transcription Factor)IBA 06/2006
1	Peptides (Polypeptides)IBA 06/2006
1	perlecanIBA 07/2004
1	Heparitin Sulfate (Heparan Sulfate)IBA 07/2004
1	LeptinIBA 06/2004
1	O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA 06/2004
1	Insulin (Novolin)FDA Link 06/2004
1	laminin 8IBA 06/2004
1	Caspase 3 (Caspase-3)IBA 05/2004
1	PlasminogenIBA 05/2004
1	AdiponectinIBA 02/2004
1	AngiostatinsIBA 11/2002
1	platelet-derived growth factor C (PDGF-C)IBA 10/2002
1	PolyphenolsIBA 07/2002
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 06/2002
1	Vascular Endothelial Growth Factor DIBA 06/2002

Therapy/Procedure

8	Therapeutics 01/2016 - 06/2002
1	Injections 08/2011
1	Ligation 08/2011